N/A
N=302
Adult Normative Performance of the Quotient ADHD System
ADHD
Bottom Line
View on ClinicalTrials.gov: NCT01308450 ↗Enrolled (actual)
302
Serious AEs
0.0%
Results posted
Oct 2013
Primary outcome: Primary: Well-screened, Non-ADHD Controls to Augment the Existing Adolescent and Adult Database Thus Expanding the Normative Reference Range of Performance of the Quotient® Adolescent and Adult Version Test. — 300 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult · 15+ yrs
- Sex
- All
- Sponsor
- BioBehavioral Diagnostics Company
- Primary completion
- Jun 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Well-screened, Non-ADHD Controls to Augment the Existing Adolescent and Adult Database Thus Expanding the Normative Reference Range of Performance of the Quotient® Adolescent and Adult Version Test. |
300 | — |
Summary
This study is being conducted to enhance and extend the clinical utility of the Quotient® ADHD System Adolescent and Adult Version Test by adding large numbers of well-screened controls to the existing Quotient® ADHD System database of adolescents and adults (ages 15-55).
Eligibility Criteria
Inclusion Criteria
Subjects are eligible for enrollment if they fulfill the following inclusion criteria:
- Male or Female
- Ages 15 to 55
- Un-medicated with medications known to affect ADHD or cognitive functioning
- Report of good physical health
- Able to understand test instructions and comply with testing
- Willing to give written informed consent and/or assent
Exclusion Criteria
- History of diagnosis of ADHD
- History of known neurological disease or insult (e.g., head trauma with LOC, skull fracture, past or present migraine headaches, seizure disorders)
- Major Medical Disorders
- Past/present alcohol or substance abuse or dependence
- Current or past DSM-IV disorder, screened by the computerized SCID I & II, and reviewed by investigator
- Any major medical or neurological condition that could affect motor activity or attention (e.g. Parkinson's, MS, dementia)
- Currently ill with cold/flu/infections which may compromise their ability to perform the computer task
Data sourced from ClinicalTrials.gov (NCT01308450). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.